No Detail Found!

The effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment

Author(s)
Eda Tanrikulu Simsek Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital,Istanbul,Turkey
Ezgi Coban Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital,Istanbul,Turkey
Elif Atag Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital,Istanbul,Turkey
Serkan Gungor Department of Nuclear Medicine, Medeniyet University Hospital,Istanbul,Turkey
Fugen Aker Department of Pathology, Haydarpasa Numune Training, and Research Hospital,Istanbul,Turkey
Murat Sari Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital,Istanbul,Turkey
Abstract
Objective: To evaluate the e ect of FDG-PET/CT in the radiological imaging of breast cancer (BC) patients planned for neoadjuvant treatment (NAT), on the clinical prognostic stage (CPS). Study Design: A descriptive study. Place and Duration of Study: Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey, between June 2014 and September 2020. Methodology: Consecutive patients with stage I-III breast cancer (BC) who were planned for neoadjuvant treatment (NAT). The distribution of CPS detected by both conventional radiological methods (c-CPS) and FDG-PET/CT (PET-CPS) were compared. Results: Signi cant upstaging on CPS was detected with the addition of FDG-PET/CT to conventional imaging methods in 25/121 (20.7%) patients (p <0.001). In the c-CPS stage, IB, IIA, IIB, IIIA, IIIB patients, the stage change rate was 22.7%, 28.6%, 37.5%, 50%, and 9.1%, respectively. There was no change in patients with c-CPS stage IA and IIIC. There was a signi cant change in the cN stages (p <0.001), while no signi cant change was detected in the cT stages of the patients (p = 0.180). Upstaging was detected in 5/16 (6.3%, p=0.034), 14/71 (19.7%, p <0.01), 15 / 30 (50%, p <0.01) of initially cN 0, 1, 2 patients, respectively (p<0.001). Conclusion: The change in CPS was due to nodal upstaging. The e ectiveness of including FDG-PET/CT in the initial radiological imaging in patients planned for NAT should be evaluated with prospective studies evaluating treatment choices to be used in NAT.
Publication Details
Page(s) 181-185
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Breast Cancer, Cancer staging, PET scan, Positron emission tomography, Neoadjuvant treatment, Staging system
0

Citations

0

Downloads

61

Views